Address: 109383,г. Москва, Ул. Песчаный карьер, дом 3, стр. 1,Russia
Tel: +7 (495) 287-77-00
Web: http://www.alliance-healthcare.ru/
Alliance Healthcare Russia is a Russian national pharmaceutical distributor and a part of the international pharmaceutical Alliance Boots Group which is the European leader in pharmacy-led health and beauty.
Alliance Healthcare Russia has 65 branches and representative offices. The company has stable position among Russian leading pharmaceutical distributors.
The project Alloga is currently being developed actively in providing customers with pre-distribution services. In October 2010 the warehouse in Klimovsk (Moscow area) was opened. This is one of the biggest and equipped warehouses all over Europe. It complies with the strictest international standards.
About three years ago one of successful European projects Alphega Pharmacy was launched. It was established in 2001 and by now membership has reached 3700 participants, they are independent pharmacies in six countries: Great Britain, France, Spain, Czech, Italy. Russia joined the organization in 2008. In total almost 600 pharmacies gathered under the brand Alphega Pharmacy in Russia.
Alliance Healthcare Russia is developing actively its key operations in pharmaceutical distribution as well as considers an opportunity of launch in Russia of completely new brands of products and services which are world-wide recognized and owned by Alliance Boots.
Distribution and retail of pharmaceutical products throughout the Russian territory.
You took over this organization just three months ago, having previously headed businesses in industries as diverse as retail, food, and automobiles. What drew you to Alliance Healthcare Russia? Do…
Although Russian authorities received heavy criticism for approving the Sputnik V vaccine prior to the completion of Phase III clinical trials, the jab is increasingly being seen as a viable…
Russia has announced that a domestically developed COVID-19 vaccine has been approved by its health authorities, the first such approval globally. However, with large-scale Phase III trials having not yet…
Below is a selection of top stories in Russian pharma from recent months, ranging from proposed changes in legislation, labelling system updates, priorities set forth by the country’s manufacturing association…
Russia is facing a drug shortage crisis which is having a particular impact on patients with life-threatening conditions. A combination of geopolitical and bureaucratic issues are restricting the flow of…
In the latest twist in the ongoing story of Russian interference in the US presidential elections of 2016, it has emerged that Russian internet trolls and automated bots spread misinformation…
In the United States, Johnson & Johnson has an image of being very close to people. Americans grow up with this company — from baby shampoo, to Tylenol when they…
You took over this organization just three months ago, having previously headed businesses in industries as diverse as retail, food, and automobiles. What drew you to Alliance Healthcare Russia? Do…
The ARPM was founded in 2002, and you were its director from 2002-2004, before leaving for a post at the Roszdravnadzor. You’ve since rejoined as director since 2007. The organization…
When Focus Reports prepared a report on the French pharmaceutical industry in 2009/10, we found that the head of the main multinational pharmaceutical association had taken a career path quite…
The U.S. and Russia have a long history of trade, and you have personally been with the American Chamber of Commerce in Russia since 2001. Can you give a brief…
The primary objectives of this association are to promote Russia as a clinical trial destination, optimize the regulatory and legislative environment, and promote the interests of ACTO members. Can you…
You have said that AstraZeneca intends to be “in Russia for Russia” and the company has recently announced a large-scale investment in this country, financing a $150Mn domestic facility in…
See our Cookie Privacy Policy Here